Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Financings Routine −

Promino Announces Settlements and Amendments of Convertible Debentures

By The Northwire Desk — AI Analysis Jun 05, 2026 · 22:04 MUSL · 0.045 Promino Nutritional Sciences Inc
MUSL · Price

Executive Summary

  • Promino Nutritional Sciences settled $373,910 in principal and accrued interest on convertible debentures by issuing 5,341,566 common shares at a deemed price of $0.07 per share.
  • The company amended the terms of certain convertible debentures with an aggregate principal amount of $711,500, extending their maturity dates by two years and significantly reducing the conversion price.

Key Details

  • Settlement of $373,910 in principal and accrued interest executed via issuance of 5,341,566 common shares.
  • Deemed issue price for settlement shares: $0.07 per common share.
  • Amendment applies to convertible debentures originally issued on June 30 and July 14, 2023, with an aggregate principal amount of $711,500.
  • Maturity dates extended by two years to June 30, 2027, and July 14, 2027.
  • Conversion price amended from $0.30 per unit to $0.07 per common share.
  • Ticker symbols referenced: CSE: MUSL, OTCID: MUSLF, FSE: 93X.
Read the original news release →

More from Promino Nutritional Sciences Inc

Jun 30, 2026 · 18:46

Former CEO lawsuit adds minor legal friction to a company battling severe liquidity constraints and inventory depletion.

Regulatory Jun 18, 2026 · 06:01

Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger

Financings Jun 09, 2026 · 06:01

Promino Launches Muscle Health Research Initiative Targeting GLP-1 Weight Management Market

Other Jun 04, 2026 · 06:01

Promino Nutritional Sciences Inc.

M&A / Property Jun 02, 2026 · 06:01

Promino(TM) Delivered to Stanley Cup Final Locker Room as Ambassador Jack Eichel Competes for Championship

M&A / Property May 26, 2026 · 07:01

Promino E-Commerce Expansion Validates Turnaround Strategy Amidst Dilution Concerns

Production / Operations